Fingolimod Hydrochloride
Who holds supplier records for Fingolimod Hydrochloride? 21 organisations hold a current record for Fingolimod Hydrochloride: an active US FDA Type II Drug Master File or a CEP. 15 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (13), Netherlands (2), Argentina (1), China (1) and 1 other country (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Fingolimod Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/fingolimod-hydrochloride
Reading the evidence
- 21 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
13 of the 18 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 12 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Fingolimod Hydrochloride expires 30 Sept 2032. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (21)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Fingolimod Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 32542, 27830 · latest filing Mar 2018
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 28057 · latest filing Mar 2014
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 26807 · latest filing Feb 2013
- Biocon LimitedIndiaCEPActive DMF 28276 · latest filing Jun 2014
- Emcure Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 28235 · latest filing Jun 2014
- HONOUR LAB LTDIndiaCEP Company GMP cert on recordActive DMF 28225 · latest filing Apr 2014
- Intas Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 28387 · latest filing Jun 2014
- MAPRIMED SAArgentinaCEP Company GMP cert on recordActive DMF 28322 · latest filing Jul 2014
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 27730 · latest filing Dec 2013
- RUYUAN HEC PHARM CO LTDCEPActive DMF 28165 · latest filing Apr 2014
- SHILPA PHARMA LIFESCIENCES LTDIndiaCEPActive DMF 28162 · latest filing May 2014
- TAPI NL BVNetherlandsCEPActive DMF 28148 · latest filing Apr 2014
- Apotex Pharmachem India Pvt. Ltd.IndiaActive DMF 27983 · latest filing Mar 2014
- NOVUGEN PHARMA MALAYSIA SDN BHDActive DMF 33328 · latest filing Dec 2018
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 28303 · latest filing Jul 2014
- TAI HENG INDUSTRY GROUP CO LTDActive DMF 28142 · latest filing Apr 2014
- Zhejiang Huahai Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 28372 · latest filing Jun 2014
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 28278 · latest filing Jun 2014
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordInactive DMF 26401 · latest filing Nov 2012
- NetherlandsCEP Company GMP cert on record
- Deva Holding A.Ş.TürkiyeCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (15)
Certificates of Suitability on the EDQM register for Fingolimod Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MAPRIMED S.A. Buenos Aires | AR | CEP 2020-312 - Rev 02 Fingolimod hydrochloride | Sept 2026 | Inspected Jul 2025 France |
| BIOCON LIMITED Bengaluru | IN | CEP 2020-156 - Rev 03 Fingolimod hydrochloride, Form-I | Aug 2026 | — |
| HONOUR LAB LIMITED Hyderabad | IN | CEP 2019-171 - Rev 02 Fingolimod hydrochloride | Aug 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2019-076 - Rev 05 Fingolimod hydrochloride | Jul 2026 | — |
| EMCURE PHARMACEUTICALS LIMITED Pune | IN | CEP 2022-413 - Rev 01 Fingolimod hydrochloride | Jun 2026 | — |
| INTAS PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2020-090 - Rev 03 Fingolimod hydrochloride, Form-I, micronised | May 2026 | — |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2020-108 - Rev 02 Fingolimod hydrochloride | May 2026 | — |
| SYNTHON B.V. Nijmegen | NL | CEP 2020-220 - Rev 01 Fingolimod hydrochloride | Mar 2026 | Inspected May 2024 Netherlands |
| RUYUAN HEC PHARM CO., LTD. Shaoguan | CN | CEP 2019-140 - Rev 02 Fingolimod hydrochloride, Form-I | Mar 2026 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2018-259 - Rev 05 Fingolimod hydrochloride | Mar 2025 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2022-164 - Rev 00 Fingolimod hydrochloride, Form-I | Oct 2024 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2019-301 - Rev 02 Fingolimod hydrochloride | Jun 2024 | — |
| MSN LABORATORIES PRIVATE LIMITED Kardanur Village | IN | R0-CEP 2021-066 - Rev 01 Fingolimod hydrochloride, Form-I | Aug 2023 | — |
| SHILPA PHARMA LIFESCIENCES LIMITED Raichur | IN | R0-CEP 2019-145 - Rev 01 Fingolimod hydrochloride | Jul 2022 | — |
| Deva Holding A.Ş. Istanbul | TR | R0-CEP 2020-352 - Rev 00 Fingolimod hydrochloride | May 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (17 listed products contain Fingolimod Hydrochloride). The latest listed patent expires 30 Sept 2032. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Fingolimod Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL544665).
Chemical identity
- IUPAC name
- 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol;hydrochloride
- Canonical SMILES
- CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl
- InChIKey
- SWZTYAVBMYWFGS-UHFFFAOYSA-N
- Synonyms
- Fingolimod, Fingolimod accord, Fingolimod (as hydrochloride), Fingolimod hcl, Fingolimod hydrochlorid, Fingolimod hydrochloride, Fingolimod mylan, FTY720, FTY-720 HYDROCHLORIDE, FTY720 HYDROCHLORIDE, Gilenia, Gilenya
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Sphingosine 1-phosphate Receptor Modulator
- Mechanism of action
- Sphingosine 1-Phosphate Receptor Modulators
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Fingolimod Hydrochloride?
21 organisations hold an active US FDA Type II Drug Master File or a CEP for Fingolimod Hydrochloride: MSN Laboratories Private Limited (India), Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), Biocon Limited (India), Emcure Pharmaceuticals Limited (India), HONOUR LAB LTD (India), Intas Pharmaceuticals Ltd. (India) and MAPRIMED SA (Argentina), and 13 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Fingolimod Hydrochloride Drug Master Files are active?
MSN Laboratories Private Limited (DMF 32542, 27830), Alembic Pharmaceuticals Limited (DMF 28057), ALIVUS LIFE SCIENCES LTD (DMF 26807), Biocon Limited (DMF 28276), Emcure Pharmaceuticals Limited (DMF 28235), HONOUR LAB LTD (DMF 28225), Intas Pharmaceuticals Ltd. (DMF 28387) and MAPRIMED SA (DMF 28322) and 10 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Fingolimod Hydrochloride have a European Certificate of Suitability?
Yes. 15 organisations hold a valid CEP for Fingolimod Hydrochloride on the EDQM register, including MAPRIMED S.A. Buenos Aires (AR), BIOCON LIMITED Bengaluru (IN), HONOUR LAB LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), EMCURE PHARMACEUTICALS LIMITED Pune (IN) and INTAS PHARMACEUTICALS LIMITED Ahmedabad (IN) and 9 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Fingolimod Hydrochloride?
Yes. The latest patent listed for an approved US product containing Fingolimod Hydrochloride expires 30 Sept 2032, across 17 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Fingolimod Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Fingolimod Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.